48
Participants
Start Date
October 11, 2011
Primary Completion Date
July 3, 2012
Study Completion Date
July 3, 2012
Gabapentin lower dose
Repeat, oral dose
Donepezil
Repeat, oral dose
Placebo (Dop)
Placebo to donepezil, Repeat, oral dose
Placebo (Gaba)
Placebo to gabapentin, Repeat, oral dose
Gabapentin higher dose
Repeat, oral dose
GSK Investigational Site, Cambridge
Lead Sponsor
GlaxoSmithKline
INDUSTRY